Model-Integrated Evidence (MIE) Industry Meeting Pilot Between FDA and Generic Drug Applicants

[FDA]

Prospective generic drug applicants and generic drug applicants who intend to use model-integrated evidence (MIE) approaches for bioequivalence (BE) establishment in their abbreviated new drug applications (ANDAs).


Baca selengkapnya di : http://www.fda.gov...